《肿瘤与内分泌》.2005年.第4期
......
- Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
- A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding
- Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer
- Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study
- The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen depriv
- No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma
- Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistan
- Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines
- Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma
- The p53-homologue p63 may promote thyroid cancer progression
- Increased risk of ovarian cancer in integrin 3 Leu33Pro homozygotes
- Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate
- Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors
- Association of polymorphisms and haplotypes in the human growth hormone 1(GH1) gene with breast cancer
- Methylation of estrogen receptor promoter correlates with loss of ER- expression in mammary carcinoma and is an early indication marker in
- Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis
- Compartmentalized expression of kallikrein 4(KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms
- Estrogen receptor- mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines
- High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas(NFPAs), even in the absence of chromosom
- Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasi
- Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer
- Emerging role of the endothelin axis in ovarian tumor progression
- Mouse models of transforming growth factor impact in breast development and cancer
- Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
- Sex steroid-producing enzymes in human breast cancer
- Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
- Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization